Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
Harmatz, Paul; Grady, Robert W.; Dragsten, Paul; Vichinsky, Elliott; Giardina, Patricia; Madden, Jacqueline; Jeng, Michael; Miller, Becky; Hanson, Gregory; Hedlund, Bo; British Journal of Haematology, 2007, vol. 138, issue 3, p 374, ISSN 00071048. ISBN 00071048.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef